Meeting
2015 Gastrointestinal Cancers Symposium
Intensity-modulated radiation therapy (IMRT) in patients with locally advanced pancreatic cancer (LAPC).
Authors
Carla Hajj
Memorial Sloan Kettering Cancer Center, New York, NY
Carla Hajj , Florence Huguet , Abraham Jing-Ching Wu , Eileen Mary O'Reilly , Corinne Winston , Diane Lauren Reidy , Peter J. Allen , Karyn A. Goodman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 377)
DOI
10.1200/jco.2015.33.3_suppl.377
Abstract #
377
Poster Bd #
C46
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer (JCOG1407).
First Author: Masato Ozaka
Poster
2019 Gastrointestinal Cancers Symposium
FOLFIRINOX in pancreatic cancer patients age 75 years or older.
First Author: Jonathan Mizrahi
Poster
2018 Gastrointestinal Cancers Symposium
Retrospective single center review of toxicity and efficacy of a modified FOLFIRINOX regimen in patients with locally advanced and metastatic pancreatic cancer.
First Author: Bhargavi Pulluri
Poster
2015 Gastrointestinal Cancers Symposium
Induction FOLFIRINOX followed by chemoradiation with capecitabine for unresectable locally advanced pancreatic cancer (LAPC): Preliminary data.
First Author: Rafael Ferreira de Carvalho